Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients

Clinical trial NCT05670054 · UNKNOWN

Trial details

NCT number: NCT05670054
Sponsor: Mansoura University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Stage IV

Start date: 2022-03-01
Primary completion: 2023-10-15
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.